Amnis Corporation: A Profile
Amnis Corporation, now part of EMD Millipore, is a prominent player in the field of digital imaging and video, specializing in high-content analysis solutions for life science research. While the company's independent website is no longer active, information about its history and contributions to the field remains accessible through other sources associated with EMD Millipore.
Core Business: Amnis Corporation developed and manufactured sophisticated flow cytometry systems, particularly the ImageStreamŽ platform. This technology combined the speed and throughput of traditional flow cytometry with the detailed morphological information provided by microscopy. This unique approach allowed researchers to analyze single cells with exceptional detail, providing a powerful tool for studying cell biology, immunology, and drug discovery. The ImageStream systems captured both brightfield and fluorescence images of individual cells as they flowed past lasers, facilitating multiparametric analysis beyond the capabilities of traditional flow cytometry.
Continue…Key Products (Historical): The flagship product was the ImageStreamŽ series of flow cytometers. These systems were characterized by their ability to acquire high-resolution images of cells, allowing researchers to correlate functional data (measured by fluorescence) with morphological characteristics. This facilitated a deeper understanding of cellular processes and responses.
Acquisition: Amnis Corporation was acquired by Millipore Corporation, which subsequently became part of Merck KGaA, operating as EMD Millipore in North America. This acquisition strategically integrated Amnis's advanced imaging technology into Millipore's broader portfolio of life science tools and reagents.
Legacy and Impact: While Amnis Corporation no longer operates as an independent entity, its technology and expertise continue to influence the field of high-content analysis. The ImageStreamŽ technology remains a valuable tool in numerous research laboratories worldwide, contributing significantly to advancements in understanding various biological processes and disease mechanisms. The company's legacy lies in its innovation in combining high-throughput flow cytometry with high-resolution imaging, pushing the boundaries of cellular analysis. Its contribution continues through the ongoing support and development of its technology by EMD Millipore.
